How to Choose an Online TRT Clinic: 8 must-do checks

A legitimate online TRT program confirms low testosterone with two morning total testosterone draws, works up secondary causes, checks baseline hematocrit, PSA where age-appropriate, and estradiol, screens for contraindications, sets a monitoring cadence, uses a licensed prescriber in your state, and offers a titration plan rather than a fixed dose.

The online TRT market has exploded, and not all of it is medicine. Some programs will prescribe testosterone off a single afternoon lab draw and a two-question intake form. Others will spend weeks working you up before they ever mention a syringe. The difference isn't branding — it's a checklist.

Here are the eight things a legitimate online TRT clinic does before you get a prescription, drawn from the Endocrine Society and American Urological Association (AUA) guidelines. If a program skips more than one or two, that's your signal.

1. They confirm low testosterone on two separate morning draws

This is the floor, not the ceiling. Testosterone follows a circadian rhythm — it peaks in the early morning and drifts down through the day. An afternoon reading can misclassify a healthy man as hypogonadal and vice versa.

Both the Endocrine Society and AUA guidelines are explicit: diagnosis requires two separate morning total testosterone measurements, ideally before 10 a.m., on different days. One low reading is a data point. Two is a diagnosis.

Any clinic willing to prescribe off a single draw — especially an afternoon one — is not practicing to guideline.

2. They pair the numbers with actual symptoms

TRT treats a syndrome, not a lab value. The AUA defines testosterone deficiency as total testosterone below roughly 300 ng/dL plus symptoms — low libido, erectile changes, fatigue, loss of morning erections, reduced muscle mass, mood changes.

A man with a total testosterone of 275 and zero symptoms is a different clinical picture than a man at 275 with six months of low libido and unexplained fatigue. A legitimate program takes a real symptom history before it treats a number.

3. They work up why your testosterone is low

Low testosterone is a finding, not a diagnosis. Before starting lifelong therapy, a thorough workup would typically include LH, FSH, prolactin, and often SHBG to distinguish primary (testicular) from secondary (pituitary/hypothalamic) hypogonadism.

Why it matters: a young man with low testosterone, low LH, and high prolactin may have a pituitary adenoma — a tumor, not a testosterone deficiency. Starting him on TRT without imaging misses the actual disease. Secondary hypogonadism in a man who still wants fertility also changes the conversation entirely, because exogenous testosterone suppresses sperm production.

4. They check baseline hematocrit, PSA, and estradiol

TRT predictably raises red blood cell mass. Erythrocytosis — a hematocrit above roughly 54% — is the most common reason to pause or dose-reduce therapy, because it thickens the blood and raises thrombotic risk.

Guidelines recommend a baseline hematocrit before starting, plus a baseline PSA and digital rectal exam in men over 40 (or younger with risk factors) to establish a reference point before therapy potentially nudges PSA upward. Estradiol is worth having as a baseline too, because a subset of men aromatize aggressively and develop symptoms — nipple tenderness, water retention, mood swings — that are easier to interpret against a known starting number.

The eight-point checklistA legitimate online TRT clinic confirms the diagnosis with two morning draws, ties it to symptoms, works up the cause, checks baseline hematocrit and PSA, screens for contraindications, uses a state-licensed prescriber, titrates dose to response, and monitors on a real schedule. Anything less is marketing.

5. They screen for contraindications and red flags

This is where prescription mills fail hardest. TRT is contraindicated or requires specialist input in men with active prostate or breast cancer, untreated severe sleep apnea, uncontrolled heart failure, a hematocrit already above 50%, or a recent cardiovascular event. Men actively trying to conceive shouldn't start testosterone monotherapy without a fertility conversation first.

The TRAVERSE trial, published in the New England Journal of Medicine in 2023, was reassuring on major cardiovascular outcomes in middle-aged and older men with hypogonadism and cardiovascular risk — but it also flagged higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. That's the kind of nuance a real clinician walks you through. It's not the kind of thing a checkout flow explains.

6. The prescriber is licensed in your state — and is actually a clinician

In the United States, controlled substance prescribing (testosterone is Schedule III) requires a licensed prescriber — MD, DO, NP, or PA — holding a license in the state where you are physically located. Not the state where the company is headquartered. Not the state where the pharmacy is.

A legitimate program tells you the name and credentials of the clinician reviewing your case. If you can't figure out who is actually writing the prescription, that's the answer.

7. They titrate the dose to your response — not a flat protocol

Standard published starting ranges for testosterone cypionate or enanthate sit in the ballpark of 100–200 mg per week, adjusted based on trough total testosterone levels drawn before the next dose, symptoms, hematocrit, and estradiol. The target for most guidelines is a mid-normal range for healthy young men.

A program that puts every patient on the same fixed dose — regardless of body size, baseline levels, or response — is not practicing individualized medicine. The Testosterone Trials and subsequent guideline commentary make clear that response is heterogeneous, and follow-up labs are what turn a starting dose into a maintenance dose.

8. They have a real monitoring cadence

If the prescription arrives and no one ever asks how you're doing, that isn't telehealth. That's mail order.

Guideline-based monitoring typically means labs at 3 months, 6 months, and then annually, checking total testosterone, hematocrit, PSA (in men over 40), and estradiol as clinically indicated, plus a symptom review. Dose changes get made against those numbers. Hematocrit above ~54% triggers a pause, a dose reduction, or a therapeutic phlebotomy conversation.

A program that ships vials indefinitely without recurring labs is not managing therapy. It is dispensing.

What this looks like at DirectCare AI

The labs worth having before a serious TRT protocol are two morning total testosterone draws, free testosterone (calculated or measured), LH, FSH, SHBG, prolactin, estradiol, a CBC for hematocrit, a comprehensive metabolic panel, PSA where age-appropriate, and a lipid panel. If you choose to run bloodwork through us, that's the panel our clinicians start with. If you bring recent labs from your PCP, those get reviewed the same way.

The brand promise is real labs, plain-English plan. That means the numbers drive the protocol, the protocol gets adjusted against follow-up numbers, and nothing about the process is a mystery to you.

Run the eight-point checklist above against any online TRT clinic — ours included. If a program can't answer all eight clearly, keep looking.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Source
2. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. Source
3. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107-117. Source
4. Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons From the Testosterone Trials. Endocr Rev. 2018;39(3):369-386. Source

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.